ReviewActa pharmaceutica Sinica. B2020

Novel agents targeting leukemia cells and immune microenvironment for prevention and treatment of relapse of acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation.

Wei Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.